C-reactive protein 2717C>T genetic polymorphism associates with esophagectomy-induced stress hyperglycemia

World Journal of Surgery

Volumn 34, Issue 5, 2010, Pages 1001-1007

  Motoyama, Satoru ^a   Miura, Masatomo ^b   Hinai, Yudai ^b   Maruyama, Kiyotomi ^a   Murata, Katsuyuki ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AGED; ARTICLE; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY;

ADIPONECTIN; AGED; C-REACTIVE PROTEIN; CYTOKINES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PPAR GAMMA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 77954690798     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0456-x     Document Type: Article

References (46)

1. Fahy BG, Sheehy AM, Coursin DB (2009) Glucose control in the intensive care unit. Crit Care Med 37:1769-1776
2. Van den Berghe G, Wouters P, Weekers F et al (2002) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
3. Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. Lancet 373:1798-1807
4. Fujita H, Kakegawa T, Yamana H et al (1995) Mortality and morbidity rates, postoperative course, quality of life and prognosis after radical lymphadenectomy for esophageal cancer. Ann Surg 222:654-662
5. Kanemaki T, Kitade H, Kaibori M et al (1998) Interleukin1 beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:1296-1303
6. Tsigos C, Papanicolaou DA, Kyrou I et al (1997) Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 82:4167-4170
7. Hu FB, Meigs JB, Li TY et al (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693-700
8. Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
9. Hu G, Jousilahti P, Tuomilehto J et al (2009) Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab 94:2099-2105
10. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
11. Yu JG, Javorschi S, Hevener AL et al (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974
12. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
13. Kim H, Haluzik M, Asghar Z et al (2003) Peroxisome proliferators- activated receptor agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 52:1770-1778
14. Flavell DM, Pineda Torra I, Jamshidi Y et al (2000) Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43:673-680
15. Day CP, Grove J, Daly AK et al (1998) Tumour necrosis factoralpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41:430-434
16. Skoog T, van't Hooft FM, Kallin B et al (1999) A common functional polymorphism (C ? A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNFalpha) gene associated with reduced circulating levels of TNFalpha. Hum Mol Genet 8:1443-1449
17. Kim TG, Kim HY, Lee SH et al (1996) Systemic lupus erythematosus with nephritis is strongly associated with the TNF.B.*2 homozygote in the Korean population. Hum Immunol 46:10-17
18. Pravica V, Perrey C, Stevens A et al (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863-866
19. Shu XO, Gao YT, Cai Q et al (2004) Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 64:836-839 (Pubitemid 38176881)
20. Graziano F, Ruzzo A, Santini D et al (2005) Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23:2339-2345
21. Lehtimäki T, Laaksonen R, Janatuinen T et al (2003) Interleukin- 1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebocontrolled positron emission tomography study in young healthy men. Pharmacogenetics 13:633-639
22. Ross OA, Curran MD, Meenagh A et al (2003) Study of ageassociation with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev 124:199-206
23. Noguchi E, Shibasaki M, Arinami T et al (1998) Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 28:449-453 (Pubitemid 28215767)
24. Buraczynska M, Jozwiak L, Ksiazek P et al (2007) Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 150:101-105
25. Wolford JK, Colligan PB, Gruber JD et al (2003) Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab 80:338-343
26. Edwards-Smith CJ, Jonsson JR, Purdie DM et al (1999) Interleukin- 10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha. Hepatology 30:526-530
27. Hall MA, McGlinn E, Coakley G et al (2000) Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1:219-224
28. Wolford JK, Gruber JD, Ossowski VM et al (2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 78:136-144
29. Russell AI, Cunninghame Graham DS et al (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13:137-147
30. Eklund C, Kivimäki M, Islam MS et al (2008) C-reactive protein genetics is associated with carotid artery compliance in men. In the cardiovascular risk in Young Finns Study. Atherosclerosis 196:841-848
31. Motoyama S, Miura M, Hinai Y et al (2009) CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann Surg Oncol 16:2479-2485
32. Katsuda Y, Asano A, Murase Y et al (2007) Association of genetic variation of the adiponectin gene with body fat distribution and carotid atherosclerosis in Japanese obese subjects. J Atheroscler Thromb 14:19-26
33. Xita N, Georgiou I, Chatzikyriakidou A et al (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51:416-423
34. Hara K, Okada T, Tobe K et al (2000) The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216
35. Umpierrez GE, Isaacs SD, Bazargan N et al (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982
36. Dronge AS, Perkal MF, Kancir S et al (2006) Long-term glycemic control and postoperative infectious complications. Arch Surg 141:375-380
37. Pasternak JJ, McGregor DG, Schroeder DR et al (2008) Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 83:406-417
38. Gandhi GY, Murad MH, Flynn DN et al (2008) Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials. Mayo Clin Proc 83:418-430
39. Clement S, Braithwaite SS, Magee MF et al (2004) Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27:553-591
40. Stith RJL (1994) Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 44:210-215
41. Wang HW, Sui SF (2001) Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun 288:75-79
42. Maeda K, Okubo K, Shimomura I et al (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript). Biochem Biophys Res Commun 221:286-289
43. Scherer PE, Williams S, Fogliano M et al (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
44. Fumeron F, Aubert R, Siddiq A et al (2004) Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: The Epidemiologic Data on the Insulin Resistance Syndrome Prospective Study. Diabetes 53:1150-1157
45. Zacharova J, Chiasson JL, Laakso M (2005) The common polymorphisms (single nucleotide polymorphism [SNP] 45 and SNP 276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes. The STOP-NIDDM Trial. Diabetes 54:893-899
46. Srámková D, Kunesová M, Hainer V et al (2002) Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population? Ann N Y Acad Sci 967:265-273